Tecovirimat Predicted to Reduce Mpox Symptom Duration by 6 Days
The use of tecovirimat for monkeypox and other non-variola orthopoxvirus infections is under an expanded access IND protocol, according to the CDC.
Majority of Eligible People Are Not Receiving Hepatitis A Vaccines
In a recent Morbidity and Mortality Weekly Report (MMWR), the results of a study showed 63% of those who died from HAV had at least 1 documented preexisting indication for vaccination.
Are Cases of Lyme Disease Underreported in the US?
Hepatitis C Treatment Initiation Low Among Medicaid Recipients
Investigators saw there was a significant difference of lower treatment initiation in people younger than 30 years old, females, Hispanic and Asian individuals, and people who inject drugs.
Norovirus Vaccine Candidate Shows Positive Results in Phase 2 Trial
Vaxart’s VP1-based bivalent oral tablet vaccine was developed to target the norovirus GI.1 Norwalk and GII.4 Sydney strains, which are the predominant strains affecting humans.
Analysis Estimates 100 Million Non-COVID-19 Adult Vaccines Missed
The report references adult vaccines, in terms of volume of use, for influenza, diphtheria and tetanus (Td), diphtheria, tetanus and pertussis (TDaP), hepatitis B, herpes zoster and pneumococcal.
Moderna Files for FDA Authorization of Updated COVID-19 Vaccine
Pending authorization of the XBB.1.5 vaccine, the company said that doses would be available in time for fall vaccination.
Pfizer, Moderna Vaccines Effective Against Omicron Infections in Children Younger Than 12
In a large observational study, significant information was obtained about mRNA vaccine protection against acute infection and disease severity.
Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval
The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
Pasteur Act Reintroduced in Congress
Both Democrats and Republicans voted to bring back the act that attempts to improve use of antibiotics
Young Children Benefit from 3 Doses of Pfizer-BioNTech COVID-19 Vaccine
The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.
COVID-19 Vaccine Included in Updated CDC Vaccine Schedule for Children and Adolescents
The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.
Investment in mRNA Technology Is Driving Force for Moderna’s Vaccine Pipeline
The company is utilizing this platform to address new COVID-19 variants, combination vaccines, and potentially prevent HIV.
2 Commerce Drive Cranbury, NJ 08512